Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM19FS3)

Drug Name
Norzimelidine Drug Info
Synonyms
Norzimeldine; 3-(4-Bromophenyl)-N-methyl-3-(3-pyridinyl)-2-propen-1-amine; 2-Propen-1-amine, 3-(4-bromophenyl)-N-methyl-3-(3-pyridinyl)-; cholesterol-3-glucose; AC1O5OK9; CHEMBL173745; SCHEMBL11636758; 60324-58-5; LS-175771; A-23889; 3-(4-bromophenyl)-N-methyl-(3-pyiidyl)allylamine oxalate
Cross-matching ID
PubChem CID
5378630
CAS Number
CAS 60324-59-6
TTD Drug ID
DM19FS3

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Monoamine uptake (MA uptake)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Desmethylclomipramine DMIESYM Discovery agent N.A. Investigative [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Monoamine uptake (MA uptake) TTJXYQ6 NOUNIPROTAC Inhibitor [1]

References

1 The antidepressant agents desipramine, fluoxetine, fluvoxamine and norzimelidine inhibit uptake of [3H]noradrenaline and [3H]5-hydroxytryptamine in slices of human and rat cortical brain tissue. Brain Res. 1983 Sep 19;275(1):99-104.
2 Do alpha2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds Eur J Pharmacol. 1999 Aug 6;378(2):161-8.